Zoetis-Neogen genomics business deal raises concerns for New Zealand regulator
MLex Summary: Zoetis and Neogen are each other’s closest rivals and the proposed acquisition would remove the existing competitive constraint they impose on each other, New Zealand’s antitrust watchdog said in...To view the full article, register now.
Already a subscriber? Click here to view full article